Sign in to view content

Board-Certified Providers Are Associated With a Reduced Risk of Endophthalmitis After Intravitreal Injections

Geoffrey G. Emerson, MD, PhD, FASRS

Video
Published 2021

Related

Differences in Intravitreal Silicone Oil Following Multiple Bevacizumab, Ranibizumab, and Aflibercept Injections
John T. Thompson, MD
Updates from the Field
2019
The Influence of Universal Face Mask Use on Endophthalmitis Risk After Intravitreal Anti-VEGF Injections During the COVID-19 Pandemic
Sunir J. Garg, MD, FACS, FASRS
Annual Meeting Talks
2021
Accuracy and Residual Volume of Commonly Used Syringes for Intravitreal Injection and the Impact on Intraocular Pressure
Gustavo Barreto de Melo, MD, PhD, FASRS
Annual Meeting Talks
2023

Category: Socioeconomics

See more